Ascendo Biotechnology is a clinical-stage biopharmaceutical company pioneering a first-in-class innate immune checkpoint platform targeting solid tumors and autoimmune diseases
Ascendo Biotechnology is a clinical-stage biopharmaceutical company pioneering a first-in-class innate immune checkpoint platform targeting solid tumors and autoimmune diseases.